391 related articles for article (PubMed ID: 22716146)
1. Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia.
Levin R; Almeida V; Peres FF; Calzavara MB; da Silva ND; Suiama MA; Niigaki ST; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
Curr Pharm Des; 2012; 18(32):4960-5. PubMed ID: 22716146
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain.
Almeida V; Peres FF; Levin R; Suiama MA; Calzavara MB; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
Schizophr Res; 2014 Mar; 153(1-3):150-9. PubMed ID: 24556469
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?
Calzavara MB; Medrano WA; Levin R; Kameda SR; Andersen ML; Tufik S; Silva RH; Frussa-Filho R; Abílio VC
Schizophr Bull; 2009 Jul; 35(4):748-59. PubMed ID: 18281713
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic-like effects of cannabidiol and rimonabant: systematic review of animal and human studies.
Roser P; Haussleiter IS
Curr Pharm Des; 2012; 18(32):5141-55. PubMed ID: 22716153
[TBL] [Abstract][Full Text] [Related]
5. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
Roser P; Vollenweider FX; Kawohl W
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):208-19. PubMed ID: 20218784
[TBL] [Abstract][Full Text] [Related]
6. Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors.
Do Monte FH; Souza RR; Bitencourt RM; Kroon JA; Takahashi RN
Behav Brain Res; 2013 Aug; 250():23-7. PubMed ID: 23643693
[TBL] [Abstract][Full Text] [Related]
7. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain.
Levin R; Peres FF; Almeida V; Calzavara MB; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
Front Pharmacol; 2014; 5():10. PubMed ID: 24567721
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors.
Hartmann A; Lisboa SF; Sonego AB; Coutinho D; Gomes FV; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109637. PubMed ID: 31054943
[TBL] [Abstract][Full Text] [Related]
9. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.
Almeida V; Levin R; Peres FF; Suiama MA; Vendramini AM; Santos CM; Silva ND; Zuardi AW; Hallak JEC; Crippa JA; Abílio VC
Neuropharmacology; 2019 Sep; 155():44-53. PubMed ID: 31103618
[TBL] [Abstract][Full Text] [Related]
10. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
Campos AC; Ortega Z; Palazuelos J; Fogaça MV; Aguiar DC; Díaz-Alonso J; Ortega-Gutiérrez S; Vázquez-Villa H; Moreira FA; Guzmán M; Galve-Roperh I; Guimarães FS
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1407-19. PubMed ID: 23298518
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test.
Almeida V; Levin R; Peres FF; Niigaki ST; Calzavara MB; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Mar; 41():30-5. PubMed ID: 23127569
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
[TBL] [Abstract][Full Text] [Related]
13. Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT₁A receptors and stressful experiences.
Marinho AL; Vila-Verde C; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Jun; 286():49-56. PubMed ID: 25701682
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors.
Rodrigues da Silva N; Gomes FV; Sonego AB; Silva NRD; Guimarães FS
Pharmacol Res; 2020 Jun; 156():104749. PubMed ID: 32151683
[TBL] [Abstract][Full Text] [Related]
15. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.
Fogaça MV; Reis FM; Campos AC; Guimarães FS
Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Zuardi AW; Crippa JA; Hallak JE; Moreira FA; Guimarães FS
Braz J Med Biol Res; 2006 Apr; 39(4):421-9. PubMed ID: 16612464
[TBL] [Abstract][Full Text] [Related]
17. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats.
Bitencourt RM; Pamplona FA; Takahashi RN
Eur Neuropsychopharmacol; 2008 Dec; 18(12):849-59. PubMed ID: 18706790
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
19. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutical use of the cannabinoids in psychiatry].
Crippa JA; Zuardi AW; Hallak JE
Braz J Psychiatry; 2010 May; 32 Suppl 1():S56-66. PubMed ID: 20512271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
